Chin Augmentation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Chin augmentation, medically termed mentoplasty or genioplasty, is a surgical procedure designed to enhance the size, projection, shape, or definition of the chin in order to improve facial harmony and proportion. The chin is a critical anchor point of facial aesthetics: a recessed or underdeveloped chin (microgenia) can make the nose appear disproportionately large and the neck undefined, while a properly projected chin creates the ideal lower-face balance and maintains aesthetic harmony between the forehead, mid-face, and jawline.

The procedure is one of the most commonly performed facial cosmetic surgeries globally, frequently combined with rhinoplasty (nose reshaping) to optimise the facial profile, or with neck liposuction to refine the cervicomental angle. Two primary surgical techniques exist: placement of a solid silicone or porous polyethylene chin implant through a small incision inside the mouth or beneath the chin, and sliding genioplasty (osteotomy) in which the chin bone is surgically repositioned and fixed with titanium plates — preferred when three-dimensional repositioning is required.

The typical patient journey begins with a comprehensive consultation where the surgeon performs facial analysis using standardised proportional guidelines. Digital imaging or 3D simulation may be used to preview expected outcomes. Surgery takes 30–90 minutes under local anaesthesia with sedation or general anaesthesia, and patients return home the same day. Swelling and bruising are moderate in the first two weeks, and the final refined result becomes visible at approximately 3 months.

Chin augmentation is primarily indicated for microgenia (small chin) and retrogenia (recessed chin), both of which create facial imbalance. Patients with a weak chin often develop compensatory neck muscle tension that exacerbates jowling and the appearance of a double chin, and augmentation corrects these proportional issues without requiring invasive facial surgery. The procedure is also used in facial gender affirmation: chin augmentation with a stronger, projecting implant is a component of masculinising facial surgery for transgender men.

Corrective chin procedures following trauma, tumour resection, or previous failed surgery also fall within the scope of mentoplasty. Congenital asymmetries and developmental mandibular hypoplasia that are not severe enough to require full orthognathic surgery may be addressed with a carefully positioned chin implant or sliding genioplasty. Surgeons frequently perform chin augmentation as part of a comprehensive facial rejuvenation when ageing has caused the lower face to lose definition.

Ideal candidates for chin augmentation are adults (typically over 18 years) with fully developed facial bones who have a chin that is too small or recessed relative to their facial proportions. Candidates must be in good general health, non-smokers or willing to abstain for at least 4 weeks before and after surgery, and have realistic expectations about surgical outcomes. Facial analysis by the surgeon confirms whether the primary issue is insufficient bone projection or soft tissue deficiency, guiding implant versus osteotomy selection.

Contraindications include active dental or periodontal infection (particularly for the intraoral approach), significant dental malocclusion requiring orthodontic and orthognathic correction rather than implant, active autoimmune conditions, or body dysmorphic disorder — which should be screened psychologically before any cosmetic surgery is offered. Sliding genioplasty is preferred over implant in patients with significant malocclusion, need for multi-directional repositioning, or prior implant failure.

Silicone chin implants are the most widely used option for augmentation, available in multiple sizes and profiles (anatomical, button, extended anatomical, total chin) to address different degrees of deficiency and provide lateral as well as anterior projection. The implant is inserted through a 1.5 cm incision either submentally (below the chin) or intraorally (inside the lower lip). A subperiosteal pocket is dissected and the implant is placed directly against the chin bone, held by tissue pressure or secured with small titanium screws.

Porous polyethylene (Medpor) implants allow fibrovascular tissue ingrowth, providing more secure fixation but making revision more complex. Sliding genioplasty involves a horizontal osteotomy of the mandibular symphysis, with the chin segment repositioned as needed and fixed with titanium plates — more versatile and preferred for complex cases. Hyaluronic acid or calcium hydroxylapatite dermal fillers offer a non-surgical temporary option for patients seeking modest projection enhancement, lasting 12–18 months without surgery. Alloplastic chin implants made from solid silicone, Medpor (porous polyethylene), or ePTFE are placed in a subperiosteal pocket via a small intraoral or submental incision. Genioplasty (osseous advancement) involves osteotomy of the chin bone at the symphysis menti, allowing precise three-dimensional repositioning (advancement, reduction, asymmetry correction) without an implant, providing a permanent and highly customisable result. Hyaluronic acid filler chin augmentation — an injectable, reversible, non-surgical option — is a temporary option for patients seeking modest projection enhancement, lasting 12–18 months without surgery.

Chin augmentation consistently delivers patient satisfaction rates of 85–95% in published studies, making it one of the most reliably satisfying facial cosmetic procedures. The improvement in facial harmony is often dramatic without appearing surgically altered — the ideal outcome is a chin that appears natural and proportionate. Studies using standardised facial aesthetic assessment show consistent improvements in the cervicomental angle, lower face height proportion, and overall facial balance following augmentation.

Recovery is relatively straightforward, with most patients returning to desk work within 7–10 days and swelling resolving by weeks 3–4. The final result is visible at approximately 3 months as residual swelling fully resolves. Chin augmentation combined with rhinoplasty is associated with particularly high satisfaction, as both procedures work synergistically to optimise the facial profile. Documented improvements in self-confidence and quality of life are significant in published outcomes research.

Chin implant surgery carries specific risks including implant malposition (asymmetric placement), which may require revision surgery in approximately 3–5% of cases. Long-term bone resorption beneath a silicone implant can occur due to sustained pressure against the mandible, though this is usually cosmetically insignificant. Infection rates are low (approximately 1–2%) but may necessitate implant removal and delayed reimplantation after 3–6 months.

Nerve-related complications include temporary or rarely permanent numbness of the lower lip and chin due to proximity of the mental nerve to the surgical field. The intraoral approach carries higher infection risk than the submental approach due to oral flora. Haematoma occurs in fewer than 2% of cases. For sliding genioplasty, additional risks include bone non-union, hardware failure, and changes to the chin's relationship with the dentition. Patients should be counselled that age-related skin changes over decades may make the implant more palpable, potentially requiring late revision.

The first week after chin augmentation involves moderate swelling, bruising, and some difficulty opening the mouth widely. A soft diet is recommended for 2 weeks. Most patients return to office work within 7–10 days. A supportive chin bandage is worn for 3–5 days to minimise swelling and stabilise the implant position. Strenuous physical activity should be avoided for 4 weeks, and contact sports for 6 weeks due to the risk of dislodging the implant before full capsular fixation.

Follow-up appointments occur at 1 week (wound check and suture removal if external approach), 4 weeks (swelling assessment), and 3 months (final photographic documentation). For sliding genioplasty, X-ray confirmation of bone healing and plate position is obtained at 6–8 weeks. Long-term follow-up is not required for uncomplicated cases, though patients are advised to return if they notice implant movement, asymmetry, pain, or signs of infection.

Chin augmentation with implant in the United States costs USD 3,000–7,000 including surgeon fees, anaesthesia, and facility charges. In the UK, private surgery costs GBP 2,500–5,000. Sliding genioplasty, being more technically complex, costs USD 5,000–12,000 in the US due to longer operative time and the hospital stay often required.

Medical tourism for chin augmentation offers significant savings. The same procedure at JCI-accredited hospitals in Thailand costs USD 1,500–3,000; in South Korea (globally recognised for facial cosmetic surgery) USD 2,000–4,500; in India USD 700–2,000; and in Turkey USD 1,000–2,500. Patients typically save 50–75% by combining the procedure with travel, and board-certified plastic surgeons at these centres have extensive international experience with facial implants. Prospective patients should verify surgeon certification and hospital JCI accreditation.

Non-surgical chin augmentation using dermal fillers (hyaluronic acid or calcium hydroxylapatite) provides temporary projection enhancement of 2–5 mm, lasting 12–18 months, without surgery or downtime. This option suits patients wanting to preview the aesthetic result before committing to surgery, or those with modest augmentation needs. Filler augmentation costs USD 500–1,500 per treatment session.

For patients whose chin deficiency is part of a broader skeletal malocclusion, comprehensive orthognathic surgery (mandibular advancement) may be the most appropriate treatment, correcting chin projection and bite function simultaneously. Orthodontic treatment alone cannot address bone-level deficiencies but may improve the dental components of facial balance. Patients should discuss all options with a plastic surgeon and oral and maxillofacial surgeon to determine the most appropriate approach for their specific anatomy.